Back to Search
Start Over
Recanalization Treatment of Acute Ischemic Stroke Caused by Large-Artery Occlusion in the Elderly: A Comparative Analysis of "the Elderly" and "the Very Elderly".
- Source :
-
Disease markers [Dis Markers] 2021 Oct 06; Vol. 2021, pp. 3579074. Date of Electronic Publication: 2021 Oct 06 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Objective: To assess whether the effectiveness and safety of recanalization therapy for acute ischemic stroke (AIS) caused by large-artery occlusion (LAO) differ between patients aged 60-79 years and patients aged ≥80 years.<br />Methods: We analyzed prospective data of patients with LAO (≥60 years) who underwent recanalization therapy at the Department of Vascular Neurosurgery, New Era Stroke Care and Research Institute, PLA Rocket Force Characteristic Medical Center, from November 2013 to July 2017. The data were compared between elderly patients (60-79 years) and very elderly patients (≥80 years). The effectiveness of recanalization therapy was evaluated using the 90-day modified Rankin scale (mRS) score, while safety was assessed by the rates of symptomatic intracranial hemorrhage (SICH) and mortality within 30 days.<br />Results: A total of 151 patients with AIS induced by LAO were included in this study. Seventy-three patients (48.3% [73/151]) had an overall favorable outcome (mRS score 0-2) after treatment. A higher proportion of patients in the elderly group showed a favorable outcome compared with the very elderly group (58.6% [34/58] vs. 41.6% [39/93], respectively; P = 0.046). The incidence of SICH (12.7% vs. 16.13%, respectively; P = 0.561) and mortality (10.3% vs. 7.5%, respectively; P = 0.548) within 30 days was not significantly different between the two groups.<br />Conclusion: Recanalization treatment of LAO is more effective in elderly patients compared with very elderly patients, while the safety of recanalization treatment is comparable between these two groups.<br />Competing Interests: All of the authors have no disclosure-conflict of interest.<br /> (Copyright © 2021 Qi Wang et al.)
- Subjects :
- Administration, Intravenous
Aged
Aged, 80 and over
Arterial Occlusive Diseases drug therapy
Cerebral Arteries pathology
Endovascular Procedures adverse effects
Female
Humans
Ischemic Stroke mortality
Male
Middle Aged
Retrospective Studies
Thrombectomy adverse effects
Thrombolytic Therapy adverse effects
Tissue Plasminogen Activator administration & dosage
Tissue Plasminogen Activator therapeutic use
Treatment Outcome
Arterial Occlusive Diseases complications
Arterial Occlusive Diseases surgery
Ischemic Stroke drug therapy
Ischemic Stroke etiology
Ischemic Stroke surgery
Subjects
Details
- Language :
- English
- ISSN :
- 1875-8630
- Volume :
- 2021
- Database :
- MEDLINE
- Journal :
- Disease markers
- Publication Type :
- Academic Journal
- Accession number :
- 34659589
- Full Text :
- https://doi.org/10.1155/2021/3579074